pre-seed
Stage
1
Investors
About
Startric develops a minimally invasive transcatheter device designed to treat tricuspid regurgitation by replicating the effective edge-to-edge Clover surgical technique through a catheter-based approach.
Explore Startric's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.